Home > Product > APIs > Lanreotide

APIs

Lanreotide

[Price Inquiry]
CAT#
10-101-45
Synonyms/Alias
Angiopeptin; Autogel; BIM-23014; BIM 23014; BIM23014; DC-13-116; Ipstyl; Somatuline; Lanreotidum; Lanreotida; Lanreotide; LS-153748; LS 153748; LS153748
CAS No.
108736-35-2
Sequence
H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bond)
M.W/Mr.
1096.33
Molecular Formula
C54H69N11O10S2
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.
Description
Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, with higher affinity to peripheral receptors, and has similar activity.
Areas of Interest
Acromegaly & Neuroendocrine tumors
Home | Site Map | Contact Us | Resources
Copyright © 2008 - Creative Peptides. All rights reserved.